Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Conditions
IgA Nephropathy (IgAN)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Huangshan City People's Hospital, Huangshan City, Anhui, China
The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China
Peking University First Hospital, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Hong Zhang, M.D.)Zhanjiang Central Hospital, Zhanjiang, Guangdong, China
Xiangya Hospital of Central South University, Changsha, Hunan, China
The Second Hospital of Jilin University, Changchun, Jilin, China
Linyi City People Hospital, Linyi, Shandong, China
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China
Xijing Hospital, Xi’an, Shanxi, China